{
    "code": "52027505",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027505",
    "time": "2021-06-04 03:18:38",
    "許可證字號": "衛部藥輸字第027505號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/09\/17",
    "發證日期": "107\/09\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202750501",
    "中文品名": "安以斯膜衣錠",
    "英文品名": "Odefsey Film-coated tablets",
    "適應症": "先前未曾使用過抗病毒藥物治療之愛滋病毒(HIV-1)感染之完整治療，且在治療開始時其病毒量HIV-1 RNA ≦100,000 copies\/mL之12歲以上(體重至少35公斤)患者；適用於特定正穩定接受抗反轉錄病毒療法，且治療開始時已達病毒學抑制狀態(HIV-1 RNA",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新複方",
    "監視期限": "112\/09\/17",
    "主成分略述": "tenofovir alafenamide fumarate, EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0284100  ROTTENDORF PHARMA GMBH",
            "製造廠廠址": "OSTENFELDER STRASSE 51-61 59320 ENNIGERLOH, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FDE0625000  Rottendorf Pharma GmbH",
            "製造廠廠址": "Am Fleigendahl 3, 59320 Ennigerloh, Germany",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "分裝"
        },
        {
            "製造廠名稱": "FIT0332200  JANSSEN-CILAG SPA",
            "製造廠廠址": "VIA C. JANSSEN, B.GO SAN MICHELE, 04100 LATINA, ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818004310",
            "成分名稱": "RILPIVIRINE HYDROCHLORIDE",
            "含量描述": "(eq to 25mg Rilpivirine)",
            "含量": "27.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818003520",
            "成分名稱": "tenofovir alafenamide fumarate",
            "含量描述": "eq to 25mg of Tenofovir Alafenamide",
            "含量": "28.0400000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818003700",
            "成分名稱": "EMTRICITABINE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Odefsey tablet photo-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027505&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版] Odefsey_EU SmPC Jul2020+USPI Aug2017_v2101_20210112-110-04-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027505&Seq=005&Type=9"
        },
        {
            "title": "Odefsey_label_v01_new add-108-03-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027505&Seq=004&Type=8"
        },
        {
            "title": "Odefsey_carton_v01_new add-108-03-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027505&Seq=003&Type=8"
        },
        {
            "title": "Odefsey_label_v01-107-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027505&Seq=002&Type=8"
        },
        {
            "title": "Odefsey_carton_v01-107-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027505&Seq=001&Type=8"
        }
    ]
}